Unigestion Holding SA boosted its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 614.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 46,510 shares of the company's stock after buying an additional 40,000 shares during the quarter. Unigestion Holding SA's holdings in Cardinal Health were worth $5,501,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the stock. Norges Bank acquired a new stake in Cardinal Health in the 4th quarter valued at approximately $246,748,000. State Street Corp raised its holdings in shares of Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company's stock valued at $1,566,913,000 after buying an additional 627,253 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Cardinal Health in the 4th quarter valued at $45,115,000. Federated Hermes Inc. lifted its stake in Cardinal Health by 55.2% during the 4th quarter. Federated Hermes Inc. now owns 578,367 shares of the company's stock worth $68,403,000 after acquiring an additional 205,818 shares in the last quarter. Finally, KLP Kapitalforvaltning AS purchased a new position in Cardinal Health during the 4th quarter valued at about $21,336,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several brokerages have recently issued reports on CAH. Bank of America increased their price target on shares of Cardinal Health from $150.00 to $155.00 and gave the stock a "buy" rating in a research report on Friday. JPMorgan Chase & Co. increased their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Wells Fargo & Company boosted their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 4th. Morgan Stanley upped their price objective on Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. Finally, Argus set a $148.00 target price on Cardinal Health in a research note on Tuesday, February 4th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $140.86.
Get Our Latest Analysis on CAH
Cardinal Health Price Performance
Shares of Cardinal Health stock traded up $2.83 during trading hours on Friday, hitting $131.71. The company had a trading volume of 699,233 shares, compared to its average volume of 2,170,154. The company's 50-day moving average is $129.20 and its two-hundred day moving average is $122.23. The company has a market cap of $31.82 billion, a P/E ratio of 24.41, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $139.50.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.54%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is 37.69%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
